So, Gilteritinib is this FLT3 inhibitor thing. It’s mainly used for Acute Myeloid Leukemia that keeps coming back or doesn’t respond to treatment, especially in folks who have these FLT3 mutations. How it works? It blocks this FLT3 kinase thing, which in turn helps to slow down leukemia cell growth.
You get it as these 40 mg tablets, all coated up for easier swallowing. The usual dose is 120 mg, and you take it just once a day. These tablets come in bottles with 90 of them in each one.